C.R. Bard, Becton Dickinson Leading Australia Vascular Access Device Market Fueled by the Introduction of New Products and Technology

February 15, 2017 (PRLEAP.COM) Health News
February 15, 2017 - Vancouver, BC – According to a new series of reports on the Australia market for vascular access devices by iData Research (www.idataresearch.com), the use of peripherally inserted central catheters (PICCs) has grown significantly at the expense of central venous catheter (CVCs). The PIVC segment is growing rapidly as new technologies enter the market to focus on reducing infection rates and make PIVCs safer and easier to use. Nurse-led placement of PICCs has been a catalyst for the increasing adoption of PICCs which significantly lowers overall procedural cost. The combination of these factors will result in overall unit sales growth in the PICCs market.

While the markets for traditional devices such as PICCs and CVCs are maturing, companies are actively investing in the development of new technological features that have increased average selling prices (ASPs) for these devices. New technologies are expected to have a significant impact on the vascular access device market. The competition in this market has spurred companies to differentiate their products in order to gain market share. This has consistently led to unique, premium-priced products.

"The more significant technological advancements will be in electrocardiogram (ECG) tip location," explains Dr. Kamran Zamanian, CEO of iData. "In addition, the increasing use of ultrasound has led to significant growth in the use of PICCs. Increasingly, ultrasound is being used for placement of PIVCs."

Previously, implantable ports were thought to be a high potential market, owing to product innovations such as power-injectable implantable ports, dual lumen ports and arm ports. However, multi-lumen implantable ports have not sold as well as previously anticipated and the prices for power-injectable implantable ports have been decreasing dramatically. The price decreases of power-injectable implantable ports have been occurring as those devices become the standard of care in Australia and as manufacturers attempt to keep and gain market share by making their power-injectable devices more economically appealing.

C. R. Bard is the leading competitor in the total Australian vascular access market. They are the strongest in the implantable port and PICC market, but also hold a significant share in the port needles market. The company has been extremely aggressive in their marketing and acquisition strategies in the vascular access market. In addition, the company continues to lead the way with new technologies, such as power-injectable devices. C. R. Bard takes advantage of the crossover between market segments and has been able to increase their presence in the rapidly growing complementary markets.

Becton Dickinson is the second leading competitor, offering a wide variety of safety products. This company continues to innovate through the introduction of new products such as the Nexiva™ closed system PIVC. Additional competitors in this market include Teleflex Medical, B. Braun, Smiths Medical, Cook Medical, Medcomp, Angiodynamics, Medtronic and Baxter among others. B. Braun continues to invest in the PIVC market, with a particular focus on the safety PIVC segment.

For Further Information
More on the vascular access device market in Australia can be found in a report suite published by iData Research entitled the Australia Market Report Suite for Vascular Access Devices and Accessories. The suite covers reports on the following markets: implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs) and dialysis catheters.

The iData report series on vascular access devices covers the U.S., Japan, South Korea, Australia, India, China, Brazil and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about vascular access device market data or procedure data, register online or email us at info@idataresearch.net for an Australia Market Report Suite for Vascular Access Devices and Accessories brochure and synopsis.

About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.

Share Article